Institutional Exposure To Genius Sports Limited (GENI)

Genius Sports Limited (GENI) concluded trading on Wednesday at a closing price of $10.22, with 3.99 million shares of worth about $40.77 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.03% during that period and on April 16, 2025 the price saw a gain of about 0.59%. Currently the company’s common shares owned by public are about 239.82M shares, out of which, 216.07M shares are available for trading.

Stock saw a price change of 6.68% in past 5 days and over the past one month there was a price change of 9.30%. Year-to-date (YTD), GENI shares are showing a performance of 18.15% which increased to 98.45% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.91 but also hit the highest price of $11.16 during that period. The average intraday trading volume for Genius Sports Limited shares is 3.29 million. The stock is currently trading 2.58% above its 20-day simple moving average (SMA20), while that difference is up 7.25% for SMA50 and it goes to 23.86% higher than SMA200.

Genius Sports Limited (NYSE: GENI) currently have 239.82M outstanding shares and institutions hold larger chunk of about 76.50% of that.

The stock has a current market capitalization of $2.64B and its 3Y-monthly beta is at 1.95. It has posted earnings per share of -$0.28 in the same period. It has Quick Ratio of 1.42 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GENI, volatility over the week remained 4.69% while standing at 6.69% over the month.

Stock’s fiscal year EPS is expected to rise by 116.77% while it is estimated to increase by 290.97% in next year.

Coverage by Guggenheim stated Genius Sports Limited (GENI) stock as a Buy in their note to investors on March 18, 2025, suggesting a price target of $12 for the stock. On June 13, 2024, Citigroup Resumed their recommendations, while on April 16, 2024, Goldman Initiated their ratings for the stock with a price target of $7.50. Stock get a Buy rating from B. Riley Securities on April 05, 2024.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.